Multimodality imaging to improve detection and prognostication of right ventricular involvement in cardiac sarcoidosis

Back

HFA Premium Access

Multimodality imaging to improve detection and prognostication of right ventricular involvement in cardiac sarcoidosis

Session: Myocardial disease - clinical 3

Topic: Clinical

Speaker: Doctor J. Okafor (London, GB)

Event: Heart Failure 2024

Congress Presentation

About the speaker

Doctor Joseph Okafor

Imperial College Healthcare NHS Trust, London (United Kingdom of Great Britain & Northern Ireland)

1 presentation

0 follower

7 more presentations in this session

Temporal trends and clinical characteristics of variant versus wild-type transthyretin amyloid cardiomyopathy in Asian population: the Korean nationwide cohort study

Speaker: Professor J. Youn (Seoul, KR)

Impact of the non-invasive diagnostic algorithm on clinical presentation and prognosis in a nationwide multicentric light-chain and transthyretin-related cardiac amyloidosis cohort

Speaker: Doctor G. Tini Melato (Rome, IT)

Validation of two clinical scores for transthyretin amyloid cardiomyopathy in a mediterranean cohort of patients at risk

Speaker: Doctor M. Llevadot Sesmilo (Badalona, ES)

Health-related quality of life in patients with symptomatic transthyretin amyloid cardiomyopathy treated with acoramidis: an EQ-5D analysis from the ATTRibute-CM study

Speaker: Doctor P. Van Der Meer (Groningen, NL)

Improved health-related quality of life in acoramidis-treated patients with ATTR-CM, demonstrated by improvements in KCCQ scores

Speaker: Professor M. Fontana (London, GB)

Access the full session

Myocardial disease - clinical 3

Speakers: Doctor J. Okafor, Professor J. Youn, Doctor G. Tini Melato, Doctor M. Llevadot Sesmilo, Doctor P. Van Der Meer...

Access

About the event

Heart Failure 2024

11 May - 14 May 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources